Compound Detail
CHEMBL4594444
PECAVAPTAN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1
Basic Information
| ChEMBL ID | CHEMBL4594444 |
| Name | PECAVAPTAN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | AZXOTZCWQDJCLY-SJCJKPOMSA-N |
4
Targets
10
Activities
2
Assay Types
0
PK Parameters
20
Publications
3
Known Names
1
Indications
2
Mechanisms
Molecular Properties
543.3
MW (Da)
3.62
ALogP
9
HBA
2
HBD
111.0
PSA (Ų)
0.37
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vasopressin V1a receptor antagonist | ANTAGONIST | Vasopressin V1a receptor | ✓ | ✓ |
| Vasopressin V2 receptor antagonist | ANTAGONIST | Vasopressin V2 receptor | ✓ | ✓ |
Indications
Heart Failure
Activity Summary
IC50 5 meas. best 8.77
Ki 5 meas. best 9.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vasopressin V1a receptor CHEMBL1889 | Ki | 9.3 | 9.09 | 0.5 | 2 |
| Vasopressin V2 receptor CHEMBL1790 | Ki | 9.22 | 9.22 | 0.6 | 1 |
| Vasopressin V2 receptor CHEMBL1790 | IC50 | 8.77 | 8.77 | 1.7 | 1 |
| Vasopressin V1a receptor CHEMBL1889 | IC50 | 8.44 | 8.305 | 3.6 | 2 |
| Oxytocin receptor CHEMBL2049 | Ki | 8.3 | 8.295 | 5.1 | 2 |
| Oxytocin receptor CHEMBL2049 | IC50 | 7.81 | 7.81 | 15.5 | 1 |
| Vasopressin V1b receptor CHEMBL1921 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5463729 | Unchecked | 26 |
| - | 10.6019/CHEMBL5463729 | Oxytocin receptor | 8 |
| - | 10.6019/CHEMBL5463729 | Vasopressin V1b receptor | 7 |
| - | 10.6019/CHEMBL5463729 | Vasopressin V1a receptor | 5 |
| - | 10.6019/CHEMBL5463729 | Tyrosine-protein kinase Lck | 3 |
| - | 10.6019/CHEMBL5463729 | Insulin receptor | 3 |
| - | 10.6019/CHEMBL5463729 | Epidermal growth factor receptor | 3 |
| - | 10.6019/CHEMBL5463729 | Voltage-dependent L-type calcium channel subunit alpha-1C | 3 |
| - | 10.6019/CHEMBL5463729 | Mitogen-activated protein kinase 14 | 2 |
| - | 10.6019/CHEMBL5463729 | Tyrosine-protein kinase HCK | 2 |
| - | 10.6019/CHEMBL5463729 | Mitogen-activated protein kinase 1 | 2 |
| - | 10.6019/CHEMBL5463729 | Protein kinase C alpha type | 2 |
| - | 10.6019/CHEMBL5463729 | Receptor tyrosine-protein kinase erbB-2 | 2 |
| - | 10.6019/CHEMBL5463729 | Vasopressin V2 receptor | 2 |
| - | 10.6019/CHEMBL5463729 | MAP kinase-activated protein kinase 2 | 2 |
| - | 10.6019/CHEMBL5463729 | Cyclin-dependent kinase 5/CDK5 activator 1 | 2 |
| - | 10.6019/CHEMBL5463729 | Tyrosine-protein kinase Fyn | 2 |
| - | 10.6019/CHEMBL5463729 | Insulin-like growth factor 1 receptor | 2 |
| - | 10.6019/CHEMBL5463729 | Ribosomal protein S6 kinase beta-1 | 2 |
| - | 10.6019/CHEMBL5463729 | D(2) dopamine receptor | 2 |
Data from ChEMBL 36 via Core Engine